Recognizing the similarities between ontogeny and oncology, p53 deficiency and stemness may collectively contribute to tumor initiation and recurrence through survival advantages, such as: disruptions in cell death programming, drug resistance and self-renewal. Here, TP53 is linked to neoplasm.